Why Partner in 2025?
With the explosion of groundbreaking news, investment, and extremely promising clinical results ripping through the GLP-1 space, 2024 was the perfect time to build meaningful relationships with key thought-leaders to understand how to aid them in developing their pipelines toward commercialization.
Returning next year, the GLP-1-Based Therapeutics Summit remains as the exclusive gathering for key biopharma players sharing a common goal: to crystallize pipeline strategy and indication expansion.
Next year's meeting will offer a unique opportunity to elevate your company’s influence with our bespoke partnership opportunities to ensure you capitalize on this rapidly growing market while supporting the development of GLP-1-based therapeutics.